Informations sur le produit
Mycro 3 is a monoclonal antibody that binds to the human protein E-cadherin, which is present on the surface of cells. This antibody inhibits the interaction between E-cadherin and beta-catenin, which is important for cellular adhesion. Mycro 3 has been shown to inhibit tumor cell growth in vitro and in vivo experiments. It has also been shown to have immunosuppressive effects on T lymphocytes and natural killer cells, which can lead to an increased risk of cancer relapse. The pharmacokinetic properties of Mycro 3 are not fully understood yet, but it is known that this drug targets the pancreas and cervical cancer cells.